Instacart’s AI-Enabled Pricing Experiments May Be Inflating Your Grocery Bill, CR and Groundwork Collaborative Investigation Finds
Derek Kravitz, Consumer Reports
XanRelax and Addall
Case Name (Date)
Brown et al. v. ZMB Enterprises LLC
22-cv-54, S.D. Cal.
(Jan. 2022)
Product/Service
XanRelax and Addall
Allegations
Misleadingly labeling products as “dietary supplements” when they contain illegal ingredients and thus do not meet the definition of “dietary supplement” under federal law
Misleadingly using the name XanRelax to make consumers believe the product provides benefits similar to the prescription drug Xanax
Misleadingly using the name Addall to make consumers believe the product provides benefits similar to the prescription drug Adderall
Falsely marketing products as able to treat, cure, and prevent diseases, including depression, anxiety, and ADHD, and without FDA approval to do so
Status
Pending
The Latest
Most Deceptive Ads of 2025
Here were some of the worst ads TINA.org investigated this year.
Cartice
Watch out for this company’s sketchy sale.
Worst False Ad Settlements of 2025
Some class-action settlements that left consumers out in the cold.
Grand Circle Cruise Line
Don’t let this post-trip extension take you for a bumpy ride.